Evidence map›Paper›PMID 40084383›Full record

ArticleCurrent research in microbial sciences2025

Identification and characterization of amphipathic antimicrobial peptides with broad spectrum activity against multi-drug resistant bacteria.

Mireia López-Siles, Ana Tajuelo, Pau Caravaca-Fuentes, Marta Planas, Lidia Feliu, Michael J McConnell

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in microbial sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mireia López-SilesMicrobiology of Intestinal Diseases, Biology Department, Universitat de Girona, Girona, Spain.
Ana TajueloIntrahospital Infections Laboratory, Instituto de Salud Carlos III (ISCIII), National Centre for Microbiology, Madrid, Spain.
Pau Caravaca-FuentesLIPPSO, Department of Chemistry, Universitat de Girona, Girona, Spain.
Marta PlanasLIPPSO, Department of Chemistry, Universitat de Girona, Girona, Spain.
Lidia FeliuLIPPSO, Department of Chemistry, Universitat de Girona, Girona, Spain.
Michael J McConnellDepartment of Biological Sciences, University of Notre Dame, Notre Dame, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are potential alternatives to antibiotics given the reduced likelihood of resistance and their high selectivity towards bacteria. AMPs with activity against antibiotic-resistant bacteria have been reported. The aim of this study is to characterize the activity of novel

Indexed as

Acinetobacter baumanniiAntibiotic resistanceAntimicrobial peptidesEscherichia coliKlebsiella pneumoniaePseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID40084383
PMCPMC11904594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.